Grant: Catalyst Grant: Cannabis Research in Urgent Priority Areas
Université de Montréal
$125,000.00
Chronic cannabis exposure in adolescent vervet monkeys
FY 2018-19
Summary
Cannabis is the most commonly used illegal drug in Canada and worldwide. Around 34% of Canadians report having consumed cannabis, half of them being youngsters aged between 15 and 24 years (Santé-Canada, 2012; Tibbo et al., 2018). The government's decision to completely legalize the use of cannabis, starting from October 2018, risks having dire consequences for both the health sector and the population in general. There is firm evidence that during adolescence, the brain continues to mature, making it susceptible to any intrusion, including that of cannabis, that will interfere with its harmonious development. Recent reports show that cannabis consumption alters critical cognitive functions such as attention, memory, emotions and social skills; chronic exposure during adolescence also increases risk for developing neuropsychiatric disorders. Most studies so far only dealt with behavioural or anatomical effects of cannabis consumption, and produced conflicting results. Moreover, most of the studies were carried out in animals using invasive and stressful drug delivery procedures. There are also many confounding factors (age, gender, dosage, chronicity, cannabis mixed with tobacco, alcohol and other drugs) that lead to major methodological flaws that prevent definite conclusions. Our objective for this one-year support is to study the pharmacokinetics of cannabis and the behavioural effects (cognition and socio-affective behaviour) of chronic cannabis consumption. The experiments will be performed on cohorts of adolescent vervet monkeys (3 to 7 years old, equivalent to 14-21 human years) kept in a naturalistic environment that will be fed daily cannabis in a candied form (e.g. brownies) compared to non-cannabis candies controls. This topic is of great scientific importance and is timely for political, social and health-economical reasons. Our results will form the basis for more comprehensive studies on cannabis use.
Department
Program
Catalyst Grant: Cannabis Research in Urgent Priority Areas
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
391417
Name
Ptito Maurice
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Cannabis Research in Urgent Priority Areas
Projecttitle
Chronic cannabis exposure in adolescent vervet monkeys
Programtype2
Operating Grants
Orgnameinp2
Université de Montréal
Cihramount2
$125,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Cannabis Research in Urgent Priority Areas
Keyworddelim
Addiction; Behaviour; Marijuana; Monkeys; Neuroscience; Pharmacokinetics
Abstract
Cannabis is the most commonly used illegal drug in Canada and worldwide. Around 34% of Canadians report having consumed cannabis, half of them being youngsters aged between 15 and 24 years (Santé-Canada, 2012; Tibbo et al., 2018). The government's decision to completely legalize the use of cannabis, starting from October 2018, risks having dire consequences for both the health sector and the population in general. There is firm evidence that during adolescence, the brain continues to mature, making it susceptible to any intrusion, including that of cannabis, that will interfere with its harmonious development. Recent reports show that cannabis consumption alters critical cognitive functions such as attention, memory, emotions and social skills; chronic exposure during adolescence also increases risk for developing neuropsychiatric disorders. Most studies so far only dealt with behavioural or anatomical effects of cannabis consumption, and produced conflicting results. Moreover, most of the studies were carried out in animals using invasive and stressful drug delivery procedures. There are also many confounding factors (age, gender, dosage, chronicity, cannabis mixed with tobacco, alcohol and other drugs) that lead to major methodological flaws that prevent definite conclusions. Our objective for this one-year support is to study the pharmacokinetics of cannabis and the behavioural effects (cognition and socio-affective behaviour) of chronic cannabis consumption. The experiments will be performed on cohorts of adolescent vervet monkeys (3 to 7 years old, equivalent to 14-21 human years) kept in a naturalistic environment that will be fed daily cannabis in a candied form (e.g. brownies) compared to non-cannabis candies controls. This topic is of great scientific importance and is timely for political, social and health-economical reasons. Our results will form the basis for more comprehensive studies on cannabis use.
Competitiondate
201810
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ptito, Maurice; Bouchard, Jean-Francois
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Neurosc Mental Hlth &A~ $125,000~ $0~